Surufatinib Clinical Trials
0 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 2
Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung Cancer
ChemoradiotherapyLimited-stage Small Cell Lung Cancer (LS-SCLC)Toripalimab+1 more
Sun Yat-sen University47 enrolled1 locationNCT06719700
Recruiting
Phase 2
Combination of Concurrent Chemoradiotherapy With Surufatinib and Tislelizumab in Patients With Locally Advanced Non-Small Cell Lung Cancer
Non-small Cell Lung CancerTislelizumabConcurrent Chemoradiotherapy+2 more
Sun Yat-sen University80 enrolled1 locationNCT07086456